BBTX insider trading
Bambusa Therapeutics, Inc.
In the past 68 days, 2 insiders bought $52.6M of Bambusa Therapeutics, Inc. stock in 2 open-market purchases. The largest purchase was $46.6M by Ra Capital Management, L.P. (Director) on Oct 30, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Helmut Wolfgang Jeggle Director Also reported by Investment GmbH Salvia |
$6.0M 375,000 sh @ $16.00 |
+4.2% | Medium
|
Nov 2, 2026 Filed Nov 2, 2026 |
Ra Capital Management, L.P. Director |
$46.6M 2,953,820 sh @ $15.79 |
– | Medium
|
Oct 30, 2026 Filed Nov 3, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.